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A b s t r a c t  
Different software programs based on mathematical models have been developed to aid the 
product development process. Recent developments in mathematics and computer science 
have resulted in new programs based on artificial neural networks (ANN) techniques. These 
programs have been used to develop and formulate pharmaceutical products. In this study, 
intelligent software was used to predict the relationship between the materials that were used 
in tablet formulation and the tablet specifications and to determine highly detailed information 
about the interactions between the formulation parameters and the specifications. The input 
data were generated from historical data and the results obtained from analyzing tablets 
produced by different formulations. The relative significance of inputs on various outputs 
such as assay, dissolution in 30 min and crushing strengths, was investigated using the 
artificial neural networks (ANNs), neurofuzzy logic and genetic programming (FormRules, 
INForm ANN and GEP).  
This study indicated that ANN and GEP can be used effectively for optimizing formulations 
and that GEP can be evaluated statistically because of the openness of its equations. 
Additionally, FormRules was very helpful for teasing out the relationships between the inputs 
(formulation variables) and the outputs. 
Keywords: Quality by Design, Artificial Neural Networks, FormRules, ramipril, spray drying, 
tablet 
 
Introduction 
Pharmaceutical product development knowledge is intensive, and 
the product development process is quite complex and takes a 
long time. Recently, the drug industry has experienced major 
developments in production information, quality management 
systems and risk management and has developed modern 
production tools that can assist in ensuring the production quality. 
A variety of tools helps manufacturers to identify, analyze, correct 
and prevent problems and constantly enhance the production 
processes. 
The drug substance ramipril is a prodrug that is transformed into 
ramiprilat, its active form, in the liver. Ramipril is demonstrated to 
decrease the mortality risk related to congestive heart failure, 
myocardial infarction, paralysis and cardiovascular events and is 
specifically used to treat hypertension (1). Different factors such 
as manufacturing process, storage conditions, moisture and 
alkaline pHs affect the stability of ramipril (2-4). Especially wet 
granulation technique, which is used to fabricate the ramipril tablet 
formulations, significantly reduces the stability of ramipril due to its 
moisture sensitivity. There are several methods for moisture 
protection of drugs including reduction of drug solubility, 
modification of chemical structure, moisture-resistant packaging 
and encapsulation of active agents (5). Encapsulation process 
also gives more stability to active agents from compression and 
other stress conditions during formulation and storage conditions. 
Spesific polymers such as HPMC and PVP have been frequently 
used to provide moisture-protection to hygroscopic and moisture-
sensitive drug substances (5,6). Spray drying is a method of 
producing a dry powder from a liquid or dispersion by rapidly 
drying with a hot air. The air supplies the heat for evaporation and 
conveys the dried product to the collector, and then the air is 
exhausted with the moisture. The feed droplets, while losing its 
moisture to hot air, remain at temperatures much below the hot air 
temperature for a very short time. Hence, spray drying is an 
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efficient encapsulation technique to produce stable powders of 
moisture and heat sensitive drugs (7,8).   
The latest advances in mathematics and computer science have 
developed methods that may aid data analysis, and thus, different 
software products based on mathematical models have been 
developed to help streamline the product development process. 
Some of the techniques include neural networks, genetic 
algorithms and fuzzy logic for optimizing pharmaceutical 
formulations (9,10). Artificial neural networks are calculation 
models inspired by biology that consist of hundreds of units and 
artificial neurons connected by factors (weights) that establish the 
neural network (9-11). Nonetheless, the most important factor in 
deciding to use genetic algorithms to solve a problem concerns 
whether the data represent the solution of the problem. Fuzzy 
logic allows the use of more instinctual statements and definers, 
which represent shades of gray, in addition to the black and white 
of conventional logic (11). 
In present study, ramipril was coated with HPMC and PVP using 
spray drying technique to improve its stability against moisture, 
compression and stress conditions. Ramipril tablets were 
fabricated by direct compression technique and two-level 
hierarchical experimental design consisting of 32 experiments 
was used to evaluate the effect of formulation variables on the 
quality of the attributes of ramipril tablets. Magnesium stearate 
(MgSt) and sodium stearyl fumarate (SSF) as lubricants was 
chosen at concentrations of 0.75-1.0% and 0.6-1.2%, 
respectively. The crushing strength, the percentage dissolution in 
30 min, the active ingredient content and the levels of impurity C 
(%) and impurity D (%) were selected as critical quality attributes 
at the end of the formulation knowledge and risk assessment 
studies. 
The models and predictions for formulation development were 
created to demonstrate the design space using the data obtained 
via these new methods and programs. 
Materials and Methods 
Materials  
Ramipril was purchased from Neuland Labs Ltd., India. 
Hydroxypropyl methylcellulose (HPMC), crospovidone (PVP) and 
yellow iron oxide from BASF, Germany; spray-dried lactose 
monohydrate from DMV, Holland; sodium hydrogen carbonate 
and red iron oxide from Merck, Germany; croscarmellose sodium 
from CP Kelco, Netherland; pregelatinized starch from Colorcon, 
England were purchased. All other chemicals were of analytical 
grade.   
Data Set 
In this study, two-level hierarchical experimental designs 
consisting of 32 experiments were used to evaluate the effect of 
two formulation variables on the quality of the attributes of ramipril 
tablets manufactured. The lubricant types were magnesium 
stearate (MgSt) and sodium stearyl fumarate (SSF). The lubricant 
concentrations studied were 0.75-1.0% for MgSt and 0.6-1.2% for 
SSF (Table 1). Tablet Formulations and Manufacturing 
The drug substances and excipients were weighed out as 
described in Table 1 to manufacture the formulations. 
Hydroxypropyl methylcellulose (HPMC) or crospovidone (PVP) 
with ramipril were dissolved in a required amount of deionized 
water. The aqueous solution was then sprayed in a Buchi B-290 
mini spray dryer with a 0.7 mm nozzle and the spray-dried powder 
was obtained in the following operating conditions: inlet 
temperature: 105°C; outlet temperature: 50-55°C; spray flow rate: 
600 L/h; pump setting: 2.5 mL/min; aspirator setting: 100%.  
Lactose monohydrate, sodium hydrogen carbonate, 
croscarmellose sodium, pregelatinized starch, yellow iron oxide 
and red iron oxide were then passed through a 0.85 mm sieve 
and mixed for 15 min in the V-type mixer (Aymes, AISI304, 
Turkey). This powder mixture was added to the spray-dried 
powder mass and mixed in same mixer for 10 min. The final 
mixture was divided into four equal parts. The first two parts were 
mixed for 2 min with MgSt, and the other two parts with SSF. The 
oblong tablets were then compressed using a tableting machine 
(Manesty, BB3B,UK) using  4.06 mm x 8.06 mm punch at 130 mg 
total tablet weight. 
Critical Quality Attributes 
The crushing strength, the percentage dissolution in 30 min, the 
active ingredient content and the levels of impurity C (%) and 
impurity D (%) were selected as critical quality attributes at the 
end of the formulation knowledge and risk assessment studies.  
The selected quality attributes were measured for the tablet 
samples, which included the crushing strength of the tablets that 
was determined using a hardness tester (Sotax HT4, 
Switzerland). A Distek dissolution system (Evolution 6100, USA) 
was used to analyze the percentage dissolution of tablets in 30 
min. The dissolution tests were conducted at the conditions 
specified in the USP 24 method II. For the assay, 10-20 tablets 
were ground to a fine powder and dissolved at a specified 
concentration in the appropriate solvent. HPLC was used to 
analyze the ramipril content in solution using the „Ramipril EP 
Reference Standards A, B, C, D‰.  
High Pressure Liquid Chromatogtraphy (HPLC) 
Analysis 
A gradient chromatographic method was used to analyze the 
ramipril content in formulations. The HPLC system consisted of a 
Thermo Separation Products (AS 3000, USA) equipped with a 
series 105 pump, a series 105 autosampler and a series 095 
UV/VIS detector. The analytical column was a Luna C18 (50 mm 
x 2.0 mm, 3 μm, Phenemonex Company, USA). The signal was 
monitored at 240 nm. The mobile phase consisted of 
Methanol:Phosphate Buffer (45:55, v/v). The flow-rate was set at 
0.4 ml/min, and the injection volume was 100 μl. The 
chromatogram time was 8 min, and the run time was 
approximately 4 min. The developed HPLC method was validated 
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according to the ICH guidelines (12). Same method was used for 
impurity analyses.  
The final product specifications and control methods for ramipril 
tablets were specified and analyzed according to the European 
Pharmacopeia (13).  
Software Tools 
Three commercial artificial intelligence software tools were used 
to obtain the production date generated in these studies. All 
software packages (INForm V.4 ANN, INForm V.4 GEP and 
FormRules V.3.32) were provided by Intelligensys Ltd., United 
Kingdom. FormRules V 3.32 is a data mining software package 
developed by Intelligensys Ltd. that makes use of the neurofuzzy 
logic as its basic technology. FormRules and Inform ANN 
software were used in these studies as previously described by 
Shao et al., 2007 (14). While a central model is established by the 
neural network element, the genetic algorithms embedded in the 
software are used for optimization (15). The Genetic Algorithm 
Program (GEP/Gene Expression Program) was used as an 
alternative to ANN for generating models to describe the linkages 
between the input and output parameters. The genetic 
programming tool operates on the principle survival of a detailed 
description of the software package has been reported in a 
previous publication (16). A mathematical expression relating the 
input parameters to an output can be generated, unlike the black-
box approach of ANNs, for which the underpinning mathematical 
relationships in the data are too complex to be interpreted. 
Training Parameters 
The parameters in INForm V.4 and FormRules V.3.32 were 
manipulated to optimize the predictability of the trained networks 
because training parameters influence the structure of the neural 
networks during the training process (14). The suggested 
parameters in the manual of INFormV.4 and FormRules V.3.32 
were suitable parameters to use after having tried a variety of 
different parameters. The FormRules settings used for training are 
given below: 
 
Model = Structural Risk Minimization (SRM) 
SRM parameter: 1 
CV parameter: 10 
Fuzzy sets   Max. submodel inputs: 4 
Max. nodes per input: 15 
 
The ANN program study conditions for this study are given in 
Table 2. 
Measurement of the predictability of the trained models 
The non-linear coefficient of determination (R2) was computed 
against the validation data set to validate the predictability of 
trained models (17). 
 
 
Results and Discussion 
The data obtained for direct compression tablets were optimized 
using INForm V.4 ANN. Once the INForm ANN model was 
trained, the model was optimized with target values according to 
the pharmacopeial and in-house specifications. The minimum and 
maximum values for optimization in the program were determined 
by considering the values for critical quality properties obtained 
from the studies. 
All critical parameters were of maximal importance, which set the 
weight value for each of them to 10. Optimization was conducted 
separately for formulations containing MgSt and SSF. 
The same evaluations were conducted by taking into account the 
in-house limits and the values for those available in pharmacopeia 
for design space studies (Table 3). 
Formulation interactions were individually evaluated for different 
ratios of HPMC:ramipril and crospovidone:ramipril (0.25:1 ? 
0.75:1) and different lubricant types and concentrations (MgSt: 
0.75% - 1.0% and SSF: 0.6% - 1.2%) by using the INForm ANN 
program.  
ANN gave the optimal formulation parameters after the training 
was completed.  
The „knowledge area‰ was provided by the optimization results 
obtained from the study data while the „design area‰ was provided 
by the optimization results obtained from in-house/pharmacopeia 
data (Table 4 and Table 5). Additionally, the knowledge and 
design area limit values were handled as area calculations; all 
values are shown in the Figures 1 and 2. 
 
The histograms in Figure 1 and 2 show that the percentage 
dissolution in 30 min and the amount of impurity D were among 
the sensitive crucial quality characteristics. The FormRules data 
show that the amount of dissolution in 30 min was inversely 
proportional to the HPMC concentration and directly proportional 
to impurity D. However, the information area in impurity C was 
broad, but because the FormRules program did not test with 
impurity C values as they were equal, no conclusions can be 
drawn about its relative impact. We concluded that we could 
decrease the high value of both our crucial quality characteristics 
because we had the opportunity to decrease the HPMC 
concentration according to the „design area‰. It should also be 
noted that impurity D was sensitive to HPMC. Moreover, the 
„design area‰ information for lubricant concentration showed that 
the lubricant concentration was fixed. When we compared the 
information area with the design area, we found that a high ratio 
of MgSt was used in formulations. The value used needed to be 
smaller because the design area parameters are fixed (Figure 2). 
Additionally, the knowledge area and design area for the 
HPMC/SSF tablets were evaluated in the same way as used for 
evaluating the HPMC/MgSt tablets. The resulting values are given 
in Table 5, and all values are shown in Figure 2 and Figure 3. 
When we examined the histogram data of the formulas, we found 
that the lubricants had a significant impact on tablets prepared by 
using HPMC/SSF (Figure 3). The HPMC concentration did not 
affect either the information or design areas, indicating that we 
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had the results required in terms of impurity D. Furthermore, the 
percentage dissolution in 30 min increased even more with a 
decrease in the HPMC concentration. Unlike the MgSt 
formulations, the SSF ratio could also be decreased in the 
HPMC/SSF formulations. The SSF ratio used in the HPMC/SSF 
formulation was irrelevant to the design area, and the impurity C 
ratio showed large deviations in the histogram. No support was 
received for evaluating impurity C in the FormRules program, 
leading to the conclusion that this formulation cannot be used. 
The knowledge area and design area evaluations were performed 
in the same way as for HPMC tablets for the PVP/MgSt and 
PVP/SSF tablets. The resulting values are given in Table 6 and 7, 
and all values are shown in Figures 5-8. 
When we evaluated the optimization results of the formulations 
prepared using PVP, the histogram data and FormRules data 
were parallel. There was a direct relationship between impurity C 
and PVP, and there was an inverse relationship between impurity 
D and PVP (Figures 5-8). However, the PVP concentration and 
lubricant ratios could also be decreased because the impurities 
are within the design area when the PVP concentration was 
decreased in the histogram of PVP/SSF. The PVP/MgSt and 
PVP/SSF amounts need to be decreased to decrease impurities 
C and D in PVP formulations. However, in this case, the limits of 
the design area become much smaller and approach a single 
point value, which is counter to the principle of providing quality 
with design. 
Conclusions 
Many tablet experiments with spray coated ramipril were carried 
out over a wide range of formulation conditions. Experimental 
relationships between ingredient ratios and outputs were 
obtained.  
The commercial software package FormRules was trained to 
generate „fuzzy rules‰, expressed linguistically, that describe the 
relationships between ingredient characteristics, process 
conditions and output properties. Using the key inputs from 
FormRules, a second commercial software package, INForm, was 
trained and optimized. The trained model was used to provide 
quantitative relationships between the same sets of inputs and 
outputs and to estimate the process parameters that are 
necessary to obtain a desired product from a given starting 
material. 
Through our study, which is focused on the formulation of design, 
we acquired substantial amounts of data, which are unobtainable 
through research and development studies, by evaluating many 
experiments to understand formulation via neural networks. 
Although neural networks were not solutions on their own, they 
supported the decision processes and were useful tools for 
obtaining the process details using the formulations. Moreover, 
artificial neural networks clearly enabled a significant time 
savings. 
Employing different computer software programs also increased 
the accuracy of the findings. The software packages that worked 
on the principle of yielding an equation like GEP were especially 
helpful in avoiding suspicious approaches, such as the artificial 
neural networks, which are „black boxes‰.  
These model studies helped develop models based on the known 
data results to estimate the unknown results for the data sets.  
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Table 1. Examples of Knowledge area data (Any information on the experimental design) 
No Formulation No HPMC: Ramipril ratio (%) PVP: Ramipril ratio (%) Lubricant 
type 
Amount of lubricant (%)
1 S1A1 0,25 : 1,0 --- MgSt 0,75 
2 S1B1 0,25 : 1,0 --- MgSt 0,75 
3 S1A2 0,25 : 1,0 --- MgSt 1,0 
4 S1B2 0,25 : 1,0 --- MgSt 1,0 
5 S1A3 0,25 : 1,0 --- SSF 0,6 
6 S1B3 0,25 : 1,0 --- SSF 0,6 
7 S1A4 0,25 : 1,0 --- SSF 1,2 
8 S1B4 0,25 : 1,0 --- SSF 1,2 
9 S2A1 0,75 : 1,0 --- MgSt 0,75 
10 S2B1 0,75 : 1,0 --- MgSt 0,75 
11 S2A2 0,75 : 1,0 --- MgSt 1,0 
12 S2B2 0,75 : 1,0 --- MgSt 1,0 
13 S2A3 0,75 : 1,0 --- SSF 0,6 
14 S2B3 0,75 : 1,0 --- SSF 0,6 
15 S2A4 0,75 : 1,0 --- SSF 1,2 
16 S2B4 0,75 : 1,0 --- SSF 1,2 
17 S3A1 --- 0,25 : 1,0 MgSt 0,75 
18 S3B1 --- 0,25 : 1,0 MgSt 0,75 
19 S3A2 --- 0,25 : 1,0 MgSt 1,0 
20 S3B2 --- 0,25 : 1,0 MgSt 1,0 
21 S3A3 --- 0,25 : 1,0 SSF 0,6 
22 S3B3 --- 0,25 : 1,0 SSF 0,6 
23 S3A4 --- 0,25 : 1,0 SSF 1,2 
24 S3B4 --- 0,25 : 1,0 SSF 1,2 
25 S4A1 --- 0,75 : 1,0 MgSt 0,75 
26 S4B1 --- 0,75 : 1,0 MgSt 0,75 
27 S4A2 --- 0,75 : 1,0 MgSt 1,0 
28 S4B2 --- 0,75 : 1,0 MgSt 1,0 
29 S4A3 --- 0,75 : 1,0 SSF 0,6 
30 S4B3 --- 0,75 : 1,0 SSF 0,6 
31 S4A4 --- 0,75 : 1,0 SSF 1,2 
32 S4B4 --- 0,75 : 1,0 SSF 1,2 
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Of the data obtained, 15% of the experimental records were separated to use as test data and for validation. The remaining data 
were used for software training. 
 
Table 2: INForm study conditions for direct compression tablets 
SG INForm ANN Study Conditions
Network Structure 
Model Type: 
 Neural Network 
Training Parameters: Inputs/Outputs
Number of hidden layers 
(HL) 
1 Back-propagation 
Parameters 
Inputs
HPMC or PVP 
Lubricant 
Lubricant Conc. Momentum 0,8
Current hidden layer 
(CHL) 
1 Learning 
rate 
0,7
Number of nodes (NN) 2 Targets Outputs
Tb. Weight 
Crush. Str. 
Friability 
Disint. Time 
Diss. in 30 min (%) 
Assay 
Imp. A 
Imp. B 
Imp. C 
Imp. D 
Imp. Total 
Ramiprilat 
Target 
epochs 
1000
Transfer function Asymmetric 
Sigmoid 
Target MS 
error 
0,0001
Output transfer function Linear Random 
seed 
1000
Parameters Apply To: All Property Models
 
 
Table 3: Usage of minimum and maximum pharmacopeia / in-house limit values for design 
space study 
 Minimum Values Maximum Values 
 Tablet 
weight 
min mid1 mid2 max desirability 
function 
Tablet 
weight 
min mid1 mid2 max desirability 
function 
Crushing 
Strength 
(N) 
10 30 30.01 30.01 60 ↓ 10 30 59.99 59.99 60 ↑ 
Diss. in 30 
min. (%) 
10 80 80.01 80.01 110 ↓ 10 80 109.99 109.99 110 ↑ 
Assay 
(mg/tb) 
10 4.5 4.51 4.51 5.5 ↓ 10 4.5 5.49 5.49 5.5 ↑ 
Imp C (%) 10 0.00 0.01 0.01 0.5 ↑ 10 0.00 0.49 0.49 0.5 ↓ 
Imp D (%) 10 0.00 0.01 0.01 3.0 ↑ 10 0.00 2.99 2.99 3.0 ↓ 
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Table 4: Knowledge and design area values of tablet parameters prepared by HPMC/MgSt 
 
 
 
 
 
 
 
 
 
 
 
Table5: Knowledge and design area values of tablet parameters prepared by spray granulation method and HPMC/SSF 
 Knowledge Area Design Area 
HPMC (%) 0.000 0.000
Lubricant concentration (%) 1.200 -0.504 
Crushing strength (N) 0.042 0.042
Dissolution at 30 min (%) 0.138 0.139
Assay (mg/tablet) 0.155 0.154
Impurity C (%) -1.820 -1.814 
Impurity D (%) 0.067 0.067
Note: The positive values show the direction of increasing; the negative values show 
the direction of decreasing as percentagedifference. 
 
Table 6: Knowledge and design area values of tablet parameters prepared by PVP/MgSt 
 
 
 
 
 
 
 
Table 7: Knowledge and design area values of tablet parameters prepared by PVP/SSF 
 
 
 
 
 
 
 
 
 
 Knowledge Area Design Area 
HPMC (%) -1.00 -0.704 
Lubricant concentration (%) -2.070 0
Crushing strength (N) 0.026 0.016 
Dissolution at 30 min (%) 0.422 0.346 
Assay (mg/tablet) 0.179 0.170 
Impurity C (%) 0.879 0.089 
Impurity D (%) -0.836 -0.733 
Note: The positive values show the direction of increasing; the negative values show 
the direction of decreasing as percentage difference. 
 Knowledge Area Design Area 
Crospovidone (%) -1.00 -1.00
Lubricant concentration 
(%) 
-0.465 -0.473 
Crushing strength (N) 0.003 -0.010 
Dissolutionin 30 min (%) 0.105 0.142 
Assay (mg/tablet) 0.208 0.202 
Impurity C (%) -0.989 -0.968 
Impurity D (%) 2.231 0.957 
Note: The positive values show the direction of increasing; the negative values show 
the direction of decreasing as percentage difference. 
 Knowledge Area Design Area 
Crospovidone (%) -1.00 -1.00
Lubricant concentration (%) -0.417 -0.420
Crushing strength (N) 0.066 0.065
Dissolution in 30 min (%) 0.138 0.139
Assay (mg/tablet) 0.194 0.193
Impurity C (%) -1.067 -0.932
Impurity D (%) 0.305 0.303
Note: The positive values show the direction of increasing; the negative values show the 
direction of decreasing as percentage difference. 
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Figure 3: Graphical image of knowledge and design area for inputs of tablets prepared by 
using HPMC/SSF 
 
 
 
 
 
 
 
 
 
Figure 4: Graphical image of knowledge and design area for outputs of tablets prepared by 
using HPMC/SSF 
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Figure 7: Graphical image of knowledge and design area for inputs of tablets prepared by 
using PVP/SSF 
 
 
 
 
 
 
 
 
Figure 8: Graphical image of knowledge and design area for outputs of tablets prepared by 
using PVP/SSF 
 
 
 
 
